Antimicrobial Evaluation of Hastishundi Leaves in Acne Treatment

Evaluation of Antimicrobial Activity of Hastishundi Heliotropium indicum Linn Leaves In-Vitro and Its Clinical Efficacy in Comparison with Clindamycin in Acne Vulgaris - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106034

Enrollment

Registered

2026-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptoms of acne vulgaris Mild and moderate category patients as per GAGS scoring system of acne.

Exclusion criteria

Exclusion criteria: Nodulystic and severe acne Use of systemic antibiotics/Retinoids in last 30 days Known allergies to Heliotropium indicum or Clindamycin Pregnant and Lactating women Critical systemic illness

Design outcomes

Primary

Measure	Time frame
To assess the Clinical efficacy of Hastishundi (Heliotropium indicum) leaves and compare it with topical clindamycin in the management of Acne vulgarisTimepoint: Baseline assessment-1st day second assessment-7th day third assessment-14th day fourth assessment-21st day fifth assessment-28th day	—

Secondary

Measure	Time frame
To determine In-vitro antimicrobial activity of Hastishundi (Helitropium indicum)leaves against acne causing microorganism Propionibacterium acne and Staphylococcus epidermisTimepoint: 6 weeks;To perform physico-chemical analysis of Heliotropium indicum leaves as per Ayurvedic Pharmacopeia standardsTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDR Prathamesh Tukaram Mote

drmanoj.kadam@gmail.com8767091736

Outcome results